ArticleCurrent issues in molecular biology2026
Walnut Green Husk Polysaccharide Improve Gut Microbiota and Alleviate Intestinal Inflammation Caused by Immune Checkpoint Inhibitors.
Article in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this study, the structure of Walnut green husk polysaccharides (WGHP) and their effects on immune checkpoint inhibitor induced colitis (ICIIC) and intestinal microbiota in mice were studied. The results showed that WGHP was composed of mannose (Man) 0.56%, rhamnose (Rha) 6.81%, galacturonic acid (GalA) 53.52%, glucose (Glc) 8.93%, galactose (Gal) 13.94%, arabinose (Ara) 15.88% and fucose (Fuc) 0.35%. The results of animal experiments showed that the intake of WGHP could not only effectively improve the phenotype of ICIIC in mice, but also significantly regulate the composition of intestinal flora and the content of short-chain fatty acids in mice, such as regulating the ratio of Firmicutes/Bacterotoides, Lachnospiraceae NK4A136 group, Lactobacillus, and increasing the content of butyric acid, acetic acid, and isobutyric acid to restore intestinal homeostasis. In addition, WGHP improves inflammation in mouse ICIIC by inhibiting the secretion of pro-inflammatory cytokines TNF-α and IL-1β, thereby activating the GPR43/PD-1/PD-L1 signaling pathway. Therefore, WGHP can be used as a functional polysaccharide for the prevention of ICIIC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.